JORDAN GRIFFETH: Open Payments
NPI 1942723549 · RIVERTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,240 in 66 payments from 16 companies in 2025. Trend: 2023 $1,474 · 2024 $1,762 · 2025 $1,240
Food & beverage: $1,240
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $364 |
| Aimmune Therapeutics, Inc. | 15 | $224 |
| Phathom Pharmaceuticals, Inc. | 3 | $109 |
| Ardelyx, Inc. | 5 | $87 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $74 |
| Janssen Biotech, Inc. | 4 | $66 |
| Regeneron Healthcare Solutions, Inc. | 3 | $60 |
| PFIZER INC. | 3 | $54 |
| GENZYME CORPORATION | 2 | $41 |
| QOL Medical, LLC | 1 | $34 |
Products named: ZENPEP, SKYRIZI, VOQUEZNA, DUPIXENT, RINVOQ, IBSRELA, JOURNAVX, TREMFYA.
Industry payments across UT — which companies pay providers there.
